Aldevron Breakthrough Blog

Aldevron capacity, capability growth key to gene, cell and protein therapeutics research

0319-GEN-logoAldevron is "Driven by a Passion to Enable Science," as featured in the April Genetic Engineering & Biotechnology News. This article spans our new production facility in Fargo, North Dakota, and the expansion of our Freiburg, Germany, antibody facility, to our expanding CRISPR options, the publication discusses our ongoing push to help researchers in their work.

One particular highlight is the discussion of our new CRISPR options, including GMP level SpyFiTM Cas9 Nuclease and the availability of in-stock GMP level prepacked CRISPR nucleases.

About the author

Latest posts



Aldevron, a biotechnology company headquartered in Fargo, N.D., offers development services and custom manufacturing of nucleic acids, proteins and antibodies, providing companies with essential components for research, clinical and commercial applications. Aldevron’s services include: GMP-Source™ and GMP plasmid manufacturing; linear DNA and mRNA production; gene synthesis; protein production; RNA synthesis enzymes; and custom antibody development with a complete biotherapeutics pipeline.

Topics: Corporate News, Genetic Engineering, news article